ID   ABI2_HUMAN              Reviewed;         513 AA.
AC   Q9NYB9; B4DSN1; Q13147; Q13249; Q13801; Q9BV70;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   18-JUN-2025, entry version 204.
DE   RecName: Full=Abl interactor 2 {ECO:0000303|Ref.16};
DE   AltName: Full=Abelson interactor 2 {ECO:0000303|Ref.16};
DE            Short=Abi-2 {ECO:0000303|PubMed:7590236};
DE   AltName: Full=Abl-binding protein 3;
DE            Short=AblBP3;
DE   AltName: Full=Arg-binding protein 1 {ECO:0000303|PubMed:8649853};
DE            Short=ArgBP1 {ECO:0000303|PubMed:8649853};
GN   Name=ABI2 {ECO:0000303|PubMed:28397838, ECO:0000312|HGNC:HGNC:24011};
GN   Synonyms=ARGBPIA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION, INTERACTION WITH ABL1, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=7590236; DOI=10.1101/gad.9.21.2569;
RA   Dai Z., Pendergast A.M.;
RT   "Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine
RT   kinase and modulates c-Abl transforming activity.";
RL   Genes Dev. 9:2569-2582(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Ren R.;
RT   "Cloning of a binding substrate of the Abl protein tyrosine kinase.";
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH ABL2, AND DOMAIN.
RC   TISSUE=Brain;
RX   PubMed=8649853;
RA   Wang B., Mysliwiec T., Krainc D., Jensen R.A., Sonoda G., Testa J.R.,
RA   Golemis E.A., Kruh G.D.;
RT   "Identification of ArgBP1, an Arg protein tyrosine kinase binding protein
RT   that is the human homologue of a CNS-specific Xenopus gene.";
RL   Oncogene 12:1921-1929(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=10498863; DOI=10.1038/sj.onc.1202911;
RA   Juang J.L., Hoffmann F.M.;
RT   "Drosophila abelson interacting protein (dAbi) is a positive regulator of
RT   abelson tyrosine kinase activity.";
RL   Oncogene 18:5138-5147(1999).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11516653; DOI=10.1016/s0960-9822(01)00239-1;
RA   Stradal T.E.B., Courtney K.D., Rottner K., Hahne P., Small J.V.,
RA   Pendergast A.M.;
RT   "The Abl interactor proteins localize to sites of actin polymerization at
RT   the tips of lamellipodia and filopodia.";
RL   Curr. Biol. 11:891-895(2001).
RN   [9]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15572692; DOI=10.1128/mcb.24.24.10905-10922.2004;
RA   Grove M., Demyanenko G., Echarri A., Zipfel P.A., Quiroz M.E.,
RA   Rodriguiz R.M., Playford M., Martensen S.A., Robinson M.R., Wetsel W.C.,
RA   Maness P.F., Pendergast A.M.;
RT   "ABI2-deficient mice exhibit defective cell migration, aberrant dendritic
RT   spine morphogenesis, and deficits in learning and memory.";
RL   Mol. Cell. Biol. 24:10905-10922(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227 AND SER-368, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-227 AND SER-368, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   INTERACTION WITH HUMAN CYTOMEGALOVIRUS PROTEIN UL135 (MICROBIAL INFECTION).
RX   PubMed=25121749; DOI=10.1016/j.chom.2014.07.005;
RA   Stanton R.J., Prod'homme V., Purbhoo M.A., Moore M., Aicheler R.J.,
RA   Heinzmann M., Bailer S.M., Haas J., Antrobus R., Weekes M.P., Lehner P.J.,
RA   Vojtesek B., Miners K.L., Man S., Wilkie G.S., Davison A.J., Wang E.C.,
RA   Tomasec P., Wilkinson G.W.;
RT   "HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition
RT   of infected cells.";
RL   Cell Host Microbe 16:201-214(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 444-508.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH3 domain of Abl interactor 2 (Abelson
RT   interactor 2).";
RL   Submitted (FEB-2008) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) OF 1-164, SUBUNIT, AND FUNCTION.
RX   PubMed=21107423; DOI=10.1038/nature09623;
RA   Chen Z., Borek D., Padrick S.B., Gomez T.S., Metlagel Z., Ismail A.M.,
RA   Umetani J., Billadeau D.D., Otwinowski Z., Rosen M.K.;
RT   "Structure and control of the actin regulatory WAVE complex.";
RL   Nature 468:533-538(2010).
RN   [18]
RP   VARIANT 132-ARG--GLU-513 DEL, AND INVOLVEMENT IN INTELLECTUAL DISABILITY.
RX   PubMed=28397838; DOI=10.1038/mp.2017.60;
RA   Harripaul R., Vasli N., Mikhailov A., Rafiq M.A., Mittal K.,
RA   Windpassinger C., Sheikh T.I., Noor A., Mahmood H., Downey S., Johnson M.,
RA   Vleuten K., Bell L., Ilyas M., Khan F.S., Khan V., Moradi M., Ayaz M.,
RA   Naeem F., Heidari A., Ahmed I., Ghadami S., Agha Z., Zeinali S., Qamar R.,
RA   Mozhdehipanah H., John P., Mir A., Ansar M., French L., Ayub M.,
RA   Vincent J.B.;
RT   "Mapping autosomal recessive intellectual disability: combined microarray
RT   and exome sequencing identifies 26 novel candidate genes in 192
RT   consanguineous families.";
RL   Mol. Psychiatry 23:973-984(2018).
CC   -!- FUNCTION: Regulator of actin cytoskeleton dynamics underlying cell
CC       motility and adhesion. Functions as a component of the WAVE complex,
CC       which activates actin nucleating machinery Arp2/3 to drive lamellipodia
CC       formation (PubMed:21107423). Acts as a regulator and substrate of
CC       nonreceptor tyrosine kinases ABL1 and ABL2 involved in processes linked
CC       to cell growth and differentiation. Positively regulates ABL1-mediated
CC       phosphorylation of ENAH, which is required for proper polymerization of
CC       nucleated actin filaments at the leading edge (PubMed:10498863,
CC       PubMed:7590236, PubMed:8649853). Contributes to the regulation of actin
CC       assembly at the tips of neuron projections. In particular, controls
CC       dendritic spine morphogenesis and may promote dendritic spine
CC       specification toward large mushroom-type spines known as repositories
CC       of memory in the brain (By similarity). In hippocampal neurons, may
CC       mediate actin-dependent BDNF-NTRK2 early endocytic trafficking that
CC       triggers dendrite outgrowth (By similarity). Participates in ocular
CC       lens morphogenesis, likely by regulating lamellipodia-driven adherens
CC       junction formation at the epithelial cell-secondary lens fiber
CC       interface (By similarity). Also required for nascent adherens junction
CC       assembly in epithelial cells (PubMed:15572692).
CC       {ECO:0000250|UniProtKB:P62484, ECO:0000269|PubMed:10498863,
CC       ECO:0000269|PubMed:15572692, ECO:0000269|PubMed:21107423,
CC       ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}.
CC   -!- SUBUNIT: Component of the WAVE complex composed of ABI2, CYFIP1 or
CC       CYFIP2, BRK1, NCKAP1 and WASF1/WAVE1. Within the complex, a heterodimer
CC       containing NCKAP1 and CYFIP1 interacts with a heterotrimer formed by
CC       WAVE1, ABI2 and BRK1. CYFIP2 binds to activated RAC1 which causes the
CC       complex to dissociate, releasing activated WASF1 (PubMed:21107423).
CC       Interacts (via SH3 domain) with ABL1 and ABL2 (PubMed:7590236,
CC       PubMed:8649853). {ECO:0000269|PubMed:21107423,
CC       ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human cytomegalovirus
CC       UL135. {ECO:0000269|PubMed:25121749}.
CC   -!- INTERACTION:
CC       Q9NYB9; Q9NYB9: ABI2; NbExp=3; IntAct=EBI-743598, EBI-743598;
CC       Q9NYB9; P00519: ABL1; NbExp=3; IntAct=EBI-743598, EBI-375543;
CC       Q9NYB9; A7KAX9: ARHGAP32; NbExp=4; IntAct=EBI-743598, EBI-308663;
CC       Q9NYB9; Q9H6L4: ARMC7; NbExp=4; IntAct=EBI-743598, EBI-742909;
CC       Q9NYB9; Q9UL45: BLOC1S6; NbExp=5; IntAct=EBI-743598, EBI-465781;
CC       Q9NYB9; Q68D86: CCDC102B; NbExp=5; IntAct=EBI-743598, EBI-10171570;
CC       Q9NYB9; Q8TD31: CCHCR1; NbExp=3; IntAct=EBI-743598, EBI-949834;
CC       Q9NYB9; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-743598, EBI-10175300;
CC       Q9NYB9; O43186: CRX; NbExp=5; IntAct=EBI-743598, EBI-748171;
CC       Q9NYB9; O60941: DTNB; NbExp=6; IntAct=EBI-743598, EBI-740402;
CC       Q9NYB9; O43281: EFS; NbExp=6; IntAct=EBI-743598, EBI-718488;
CC       Q9NYB9; Q9H6Z9: EGLN3; NbExp=3; IntAct=EBI-743598, EBI-1175354;
CC       Q9NYB9; Q6IB98: EIF3S3; NbExp=3; IntAct=EBI-743598, EBI-10184995;
CC       Q9NYB9; Q96CN9: GCC1; NbExp=4; IntAct=EBI-743598, EBI-746252;
CC       Q9NYB9; O14964: HGS; NbExp=5; IntAct=EBI-743598, EBI-740220;
CC       Q9NYB9; P61978: HNRNPK; NbExp=6; IntAct=EBI-743598, EBI-304185;
CC       Q9NYB9; Q9NSC5: HOMER3; NbExp=8; IntAct=EBI-743598, EBI-748420;
CC       Q9NYB9; Q8IY31: IFT20; NbExp=6; IntAct=EBI-743598, EBI-744203;
CC       Q9NYB9; Q8IYA8: IHO1; NbExp=6; IntAct=EBI-743598, EBI-8638439;
CC       Q9NYB9; Q5T5P2-6: KIAA1217; NbExp=3; IntAct=EBI-743598, EBI-10188326;
CC       Q9NYB9; Q9BVG8: KIFC3; NbExp=5; IntAct=EBI-743598, EBI-2125614;
CC       Q9NYB9; A1A4E9: KRT13; NbExp=3; IntAct=EBI-743598, EBI-10171552;
CC       Q9NYB9; P19012: KRT15; NbExp=6; IntAct=EBI-743598, EBI-739566;
CC       Q9NYB9; P08727: KRT19; NbExp=3; IntAct=EBI-743598, EBI-742756;
CC       Q9NYB9; P35900: KRT20; NbExp=3; IntAct=EBI-743598, EBI-742094;
CC       Q9NYB9; Q15323: KRT31; NbExp=5; IntAct=EBI-743598, EBI-948001;
CC       Q9NYB9; Q14525: KRT33B; NbExp=3; IntAct=EBI-743598, EBI-1049638;
CC       Q9NYB9; P25791: LMO2; NbExp=5; IntAct=EBI-743598, EBI-739696;
CC       Q9NYB9; Q96HT8: MRFAP1L1; NbExp=7; IntAct=EBI-743598, EBI-748896;
CC       Q9NYB9; Q9H9J2: MRPL44; NbExp=3; IntAct=EBI-743598, EBI-713619;
CC       Q9NYB9; O43639: NCK2; NbExp=8; IntAct=EBI-743598, EBI-713635;
CC       Q9NYB9; P37198: NUP62; NbExp=6; IntAct=EBI-743598, EBI-347978;
CC       Q9NYB9; Q15154: PCM1; NbExp=3; IntAct=EBI-743598, EBI-741421;
CC       Q9NYB9; Q13526: PIN1; NbExp=5; IntAct=EBI-743598, EBI-714158;
CC       Q9NYB9; P30405: PPIF; NbExp=4; IntAct=EBI-743598, EBI-5544229;
CC       Q9NYB9; Q96QH2: PRAM1; NbExp=3; IntAct=EBI-743598, EBI-2860740;
CC       Q9NYB9; Q13131: PRKAA1; NbExp=5; IntAct=EBI-743598, EBI-1181405;
CC       Q9NYB9; P54646: PRKAA2; NbExp=5; IntAct=EBI-743598, EBI-1383852;
CC       Q9NYB9; Q569H4: PRR16; NbExp=4; IntAct=EBI-743598, EBI-5564642;
CC       Q9NYB9; O00560: SDCBP; NbExp=5; IntAct=EBI-743598, EBI-727004;
CC       Q9NYB9; O75886: STAM2; NbExp=5; IntAct=EBI-743598, EBI-373258;
CC       Q9NYB9; Q9UBB9: TFIP11; NbExp=6; IntAct=EBI-743598, EBI-1105213;
CC       Q9NYB9; Q08117: TLE5; NbExp=5; IntAct=EBI-743598, EBI-717810;
CC       Q9NYB9; Q13049: TRIM32; NbExp=8; IntAct=EBI-743598, EBI-742790;
CC       Q9NYB9; Q15654: TRIP6; NbExp=5; IntAct=EBI-743598, EBI-742327;
CC       Q9NYB9; Q5ST30-4: VARS2; NbExp=3; IntAct=EBI-743598, EBI-10244997;
CC       Q9NYB9; P50552: VASP; NbExp=5; IntAct=EBI-743598, EBI-748201;
CC       Q9NYB9; P18206: VCL; NbExp=3; IntAct=EBI-743598, EBI-716775;
CC       Q9NYB9; Q9Y3C0: WASHC3; NbExp=4; IntAct=EBI-743598, EBI-712969;
CC       Q9NYB9; O43516: WIPF1; NbExp=4; IntAct=EBI-743598, EBI-346356;
CC       Q9NYB9; Q8VHK2: Caskin1; Xeno; NbExp=3; IntAct=EBI-743598, EBI-7049475;
CC       Q9NYB9-2; Q8IZP0-5: ABI1; NbExp=3; IntAct=EBI-11096309, EBI-11743294;
CC       Q9NYB9-2; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-11096309, EBI-11096309;
CC       Q9NYB9-2; Q9P2A4: ABI3; NbExp=5; IntAct=EBI-11096309, EBI-742038;
CC       Q9NYB9-2; P42684-3: ABL2; NbExp=3; IntAct=EBI-11096309, EBI-10693977;
CC       Q9NYB9-2; O94929-2: ABLIM3; NbExp=3; IntAct=EBI-11096309, EBI-11961672;
CC       Q9NYB9-2; Q5BKX5-3: ACTMAP; NbExp=5; IntAct=EBI-11096309, EBI-11976299;
CC       Q9NYB9-2; Q9NX04: AIRIM; NbExp=3; IntAct=EBI-11096309, EBI-8643161;
CC       Q9NYB9-2; Q9ULX6: AKAP8L; NbExp=3; IntAct=EBI-11096309, EBI-357530;
CC       Q9NYB9-2; Q6PJH3: AKAP9; NbExp=3; IntAct=EBI-11096309, EBI-11745576;
CC       Q9NYB9-2; Q3KP44: ANKRD55; NbExp=3; IntAct=EBI-11096309, EBI-14493093;
CC       Q9NYB9-2; Q49AR9: ANKS1A; NbExp=3; IntAct=EBI-11096309, EBI-11954519;
CC       Q9NYB9-2; Q7L5A3: ATOSB; NbExp=3; IntAct=EBI-11096309, EBI-745689;
CC       Q9NYB9-2; Q9Y6H3: ATP23; NbExp=3; IntAct=EBI-11096309, EBI-12811889;
CC       Q9NYB9-2; O95429: BAG4; NbExp=5; IntAct=EBI-11096309, EBI-2949658;
CC       Q9NYB9-2; Q9NQY0: BIN3; NbExp=7; IntAct=EBI-11096309, EBI-2653038;
CC       Q9NYB9-2; Q8TDH9: BLOC1S5; NbExp=3; IntAct=EBI-11096309, EBI-465861;
CC       Q9NYB9-2; Q9UL45: BLOC1S6; NbExp=6; IntAct=EBI-11096309, EBI-465781;
CC       Q9NYB9-2; Q96GS4: BORCS6; NbExp=5; IntAct=EBI-11096309, EBI-10193358;
CC       Q9NYB9-2; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-11096309, EBI-747505;
CC       Q9NYB9-2; A1L168: C20orf202; NbExp=3; IntAct=EBI-11096309, EBI-18396958;
CC       Q9NYB9-2; Q53FE4: C4orf17; NbExp=3; IntAct=EBI-11096309, EBI-715110;
CC       Q9NYB9-2; Q68D86: CCDC102B; NbExp=3; IntAct=EBI-11096309, EBI-10171570;
CC       Q9NYB9-2; Q96NT0: CCDC115; NbExp=5; IntAct=EBI-11096309, EBI-2810325;
CC       Q9NYB9-2; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-11096309, EBI-10961624;
CC       Q9NYB9-2; Q96LY2-2: CCDC74B; NbExp=3; IntAct=EBI-11096309, EBI-17967022;
CC       Q9NYB9-2; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-11096309, EBI-10175300;
CC       Q9NYB9-2; Q9H3R5: CENPH; NbExp=6; IntAct=EBI-11096309, EBI-1003700;
CC       Q9NYB9-2; Q7L2Z9: CENPQ; NbExp=3; IntAct=EBI-11096309, EBI-2350265;
CC       Q9NYB9-2; Q9C0F1: CEP44; NbExp=3; IntAct=EBI-11096309, EBI-744115;
CC       Q9NYB9-2; Q86XR8-3: CEP57; NbExp=3; IntAct=EBI-11096309, EBI-11752486;
CC       Q9NYB9-2; A8MTA8-2: CIMIP2B; NbExp=3; IntAct=EBI-11096309, EBI-12160437;
CC       Q9NYB9-2; Q16740: CLPP; NbExp=3; IntAct=EBI-11096309, EBI-1056029;
CC       Q9NYB9-2; Q96JB2-2: COG3; NbExp=3; IntAct=EBI-11096309, EBI-9091495;
CC       Q9NYB9-2; Q9NWM3: CUEDC1; NbExp=3; IntAct=EBI-11096309, EBI-5838167;
CC       Q9NYB9-2; Q13561: DCTN2; NbExp=3; IntAct=EBI-11096309, EBI-715074;
CC       Q9NYB9-2; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-11096309, EBI-11988027;
CC       Q9NYB9-2; Q9P1A6-3: DLGAP2; NbExp=3; IntAct=EBI-11096309, EBI-12019838;
CC       Q9NYB9-2; Q9Y2H0-1: DLGAP4; NbExp=3; IntAct=EBI-11096309, EBI-12000556;
CC       Q9NYB9-2; Q6TDU7: DNAI7; NbExp=3; IntAct=EBI-11096309, EBI-5235378;
CC       Q9NYB9-2; O60941-5: DTNB; NbExp=5; IntAct=EBI-11096309, EBI-11984733;
CC       Q9NYB9-2; O43281-2: EFS; NbExp=5; IntAct=EBI-11096309, EBI-11525448;
CC       Q9NYB9-2; Q05215: EGR4; NbExp=3; IntAct=EBI-11096309, EBI-19949420;
CC       Q9NYB9-2; Q9H0I2: ENKD1; NbExp=6; IntAct=EBI-11096309, EBI-744099;
CC       Q9NYB9-2; Q8TE68-2: EPS8L1; NbExp=3; IntAct=EBI-11096309, EBI-12003490;
CC       Q9NYB9-2; Q96MY7: FAM161B; NbExp=3; IntAct=EBI-11096309, EBI-7225287;
CC       Q9NYB9-2; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-11096309, EBI-6658203;
CC       Q9NYB9-2; Q8IZT9: FAM9C; NbExp=3; IntAct=EBI-11096309, EBI-2870039;
CC       Q9NYB9-2; Q6PCT2-2: FBXL19; NbExp=3; IntAct=EBI-11096309, EBI-11959077;
CC       Q9NYB9-2; Q5TD97: FHL5; NbExp=3; IntAct=EBI-11096309, EBI-750641;
CC       Q9NYB9-2; Q0VDC6: FKBP1A; NbExp=3; IntAct=EBI-11096309, EBI-10226858;
CC       Q9NYB9-2; Q9NU39: FOXD4L1; NbExp=3; IntAct=EBI-11096309, EBI-11320806;
CC       Q9NYB9-2; Q8NHY3: GAS2L2; NbExp=3; IntAct=EBI-11096309, EBI-7960826;
CC       Q9NYB9-2; P14136: GFAP; NbExp=6; IntAct=EBI-11096309, EBI-744302;
CC       Q9NYB9-2; Q86UU5: GGN; NbExp=3; IntAct=EBI-11096309, EBI-10259069;
CC       Q9NYB9-2; O95872: GPANK1; NbExp=3; IntAct=EBI-11096309, EBI-751540;
CC       Q9NYB9-2; Q03014: HHEX; NbExp=3; IntAct=EBI-11096309, EBI-747421;
CC       Q9NYB9-2; P61978-2: HNRNPK; NbExp=6; IntAct=EBI-11096309, EBI-7060731;
CC       Q9NYB9-2; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-11096309, EBI-748420;
CC       Q9NYB9-2; O75031: HSF2BP; NbExp=3; IntAct=EBI-11096309, EBI-7116203;
CC       Q9NYB9-2; Q8IY31-3: IFT20; NbExp=7; IntAct=EBI-11096309, EBI-9091197;
CC       Q9NYB9-2; Q8IYA8: IHO1; NbExp=3; IntAct=EBI-11096309, EBI-8638439;
CC       Q9NYB9-2; Q0VD86: INCA1; NbExp=3; IntAct=EBI-11096309, EBI-6509505;
CC       Q9NYB9-2; Q9C086: INO80B; NbExp=3; IntAct=EBI-11096309, EBI-715611;
CC       Q9NYB9-2; Q2T9L4: INSYN1; NbExp=3; IntAct=EBI-11096309, EBI-4311436;
CC       Q9NYB9-2; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-11096309, EBI-1055254;
CC       Q9NYB9-2; Q5T5P2-6: KIAA1217; NbExp=3; IntAct=EBI-11096309, EBI-10188326;
CC       Q9NYB9-2; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-11096309, EBI-14069005;
CC       Q9NYB9-2; Q9Y448: KNSTRN; NbExp=3; IntAct=EBI-11096309, EBI-373334;
CC       Q9NYB9-2; P02533: KRT14; NbExp=3; IntAct=EBI-11096309, EBI-702178;
CC       Q9NYB9-2; P19012: KRT15; NbExp=3; IntAct=EBI-11096309, EBI-739566;
CC       Q9NYB9-2; P08727: KRT19; NbExp=3; IntAct=EBI-11096309, EBI-742756;
CC       Q9NYB9-2; Q2M2I5: KRT24; NbExp=3; IntAct=EBI-11096309, EBI-2952736;
CC       Q9NYB9-2; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-11096309, EBI-3044087;
CC       Q9NYB9-2; O76011: KRT34; NbExp=3; IntAct=EBI-11096309, EBI-1047093;
CC       Q9NYB9-2; O76013-2: KRT36; NbExp=3; IntAct=EBI-11096309, EBI-11958506;
CC       Q9NYB9-2; O95678: KRT75; NbExp=3; IntAct=EBI-11096309, EBI-2949715;
CC       Q9NYB9-2; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-11096309, EBI-726510;
CC       Q9NYB9-2; Q3B8N2: LGALS9B; NbExp=3; IntAct=EBI-11096309, EBI-10240775;
CC       Q9NYB9-2; Q9UBR4-2: LHX3; NbExp=3; IntAct=EBI-11096309, EBI-12039345;
CC       Q9NYB9-2; Q68G74: LHX8; NbExp=3; IntAct=EBI-11096309, EBI-8474075;
CC       Q9NYB9-2; P25800: LMO1; NbExp=8; IntAct=EBI-11096309, EBI-8639312;
CC       Q9NYB9-2; P25791-3: LMO2; NbExp=6; IntAct=EBI-11096309, EBI-11959475;
CC       Q9NYB9-2; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-11096309, EBI-11742507;
CC       Q9NYB9-2; P61968: LMO4; NbExp=3; IntAct=EBI-11096309, EBI-2798728;
CC       Q9NYB9-2; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-11096309, EBI-739832;
CC       Q9NYB9-2; Q96LR2: LURAP1; NbExp=3; IntAct=EBI-11096309, EBI-741355;
CC       Q9NYB9-2; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-11096309, EBI-741037;
CC       Q9NYB9-2; P43355: MAGEA1; NbExp=3; IntAct=EBI-11096309, EBI-740978;
CC       Q9NYB9-2; Q9BTT4: MED10; NbExp=3; IntAct=EBI-11096309, EBI-394354;
CC       Q9NYB9-2; Q9P086: MED11; NbExp=3; IntAct=EBI-11096309, EBI-394704;
CC       Q9NYB9-2; Q9NX70: MED29; NbExp=3; IntAct=EBI-11096309, EBI-394656;
CC       Q9NYB9-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-11096309, EBI-16439278;
CC       Q9NYB9-2; Q9Y605: MRFAP1; NbExp=5; IntAct=EBI-11096309, EBI-995714;
CC       Q9NYB9-2; Q13084: MRPL28; NbExp=3; IntAct=EBI-11096309, EBI-723426;
CC       Q9NYB9-2; Q96JP2: MYO15B; NbExp=3; IntAct=EBI-11096309, EBI-7950783;
CC       Q9NYB9-2; P15173: MYOG; NbExp=3; IntAct=EBI-11096309, EBI-3906629;
CC       Q9NYB9-2; Q8TDC0: MYOZ3; NbExp=3; IntAct=EBI-11096309, EBI-5662487;
CC       Q9NYB9-2; A0A0S2Z4D7: NCK1; NbExp=3; IntAct=EBI-11096309, EBI-16429340;
CC       Q9NYB9-2; A0A0S2Z4E4: NCK1; NbExp=3; IntAct=EBI-11096309, EBI-16432934;
CC       Q9NYB9-2; O43639: NCK2; NbExp=10; IntAct=EBI-11096309, EBI-713635;
CC       Q9NYB9-2; Q9NZQ3-3: NCKIPSD; NbExp=3; IntAct=EBI-11096309, EBI-10963850;
CC       Q9NYB9-2; O94856-3: NFASC; NbExp=3; IntAct=EBI-11096309, EBI-12035911;
CC       Q9NYB9-2; Q5HYW2: NHSL2; NbExp=9; IntAct=EBI-11096309, EBI-2859639;
CC       Q9NYB9-2; O00746: NME4; NbExp=3; IntAct=EBI-11096309, EBI-744871;
CC       Q9NYB9-2; O43482: OIP5; NbExp=3; IntAct=EBI-11096309, EBI-536879;
CC       Q9NYB9-2; A6NGQ2: OOEP; NbExp=3; IntAct=EBI-11096309, EBI-18583589;
CC       Q9NYB9-2; Q13177: PAK2; NbExp=3; IntAct=EBI-11096309, EBI-1045887;
CC       Q9NYB9-2; Q15154-3: PCM1; NbExp=3; IntAct=EBI-11096309, EBI-11742977;
CC       Q9NYB9-2; Q9NR12: PDLIM7; NbExp=3; IntAct=EBI-11096309, EBI-350517;
CC       Q9NYB9-2; Q99471: PFDN5; NbExp=3; IntAct=EBI-11096309, EBI-357275;
CC       Q9NYB9-2; Q8N4B1-4: PHETA1; NbExp=8; IntAct=EBI-11096309, EBI-14131832;
CC       Q9NYB9-2; O43189: PHF1; NbExp=3; IntAct=EBI-11096309, EBI-530034;
CC       Q9NYB9-2; Q13526: PIN1; NbExp=3; IntAct=EBI-11096309, EBI-714158;
CC       Q9NYB9-2; Q494U1-3: PLEKHN1; NbExp=3; IntAct=EBI-11096309, EBI-12014286;
CC       Q9NYB9-2; P01189: POMC; NbExp=3; IntAct=EBI-11096309, EBI-12219503;
CC       Q9NYB9-2; P30405: PPIF; NbExp=3; IntAct=EBI-11096309, EBI-5544229;
CC       Q9NYB9-2; Q08209-2: PPP3CA; NbExp=3; IntAct=EBI-11096309, EBI-11959013;
CC       Q9NYB9-2; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-11096309, EBI-3957793;
CC       Q9NYB9-2; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-11096309, EBI-11320284;
CC       Q9NYB9-2; P54646: PRKAA2; NbExp=3; IntAct=EBI-11096309, EBI-1383852;
CC       Q9NYB9-2; Q569H4: PRR16; NbExp=8; IntAct=EBI-11096309, EBI-5564642;
CC       Q9NYB9-2; P86480: PRR20D; NbExp=3; IntAct=EBI-11096309, EBI-12754095;
CC       Q9NYB9-2; P25786: PSMA1; NbExp=3; IntAct=EBI-11096309, EBI-359352;
CC       Q9NYB9-2; Q6NUJ5: PWWP2B; NbExp=3; IntAct=EBI-11096309, EBI-10251192;
CC       Q9NYB9-2; Q15276: RABEP1; NbExp=3; IntAct=EBI-11096309, EBI-447043;
CC       Q9NYB9-2; Q9UJ41-4: RABGEF1; NbExp=3; IntAct=EBI-11096309, EBI-14093916;
CC       Q9NYB9-2; Q9Y272: RASD1; NbExp=3; IntAct=EBI-11096309, EBI-740818;
CC       Q9NYB9-2; Q15287: RNPS1; NbExp=3; IntAct=EBI-11096309, EBI-395959;
CC       Q9NYB9-2; Q9BUL9: RPP25; NbExp=3; IntAct=EBI-11096309, EBI-366570;
CC       Q9NYB9-2; Q9UHP6: RSPH14; NbExp=3; IntAct=EBI-11096309, EBI-748350;
CC       Q9NYB9-2; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-11096309, EBI-6257312;
CC       Q9NYB9-2; O76038: SCGN; NbExp=3; IntAct=EBI-11096309, EBI-749420;
CC       Q9NYB9-2; Q9Y3L3: SH3BP1; NbExp=3; IntAct=EBI-11096309, EBI-346869;
CC       Q9NYB9-2; Q13239-3: SLA; NbExp=3; IntAct=EBI-11096309, EBI-17630587;
CC       Q9NYB9-2; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-11096309, EBI-358489;
CC       Q9NYB9-2; O60641-3: SNAP91; NbExp=3; IntAct=EBI-11096309, EBI-12854506;
CC       Q9NYB9-2; O95295: SNAPIN; NbExp=5; IntAct=EBI-11096309, EBI-296723;
CC       Q9NYB9-2; Q96RF0: SNX18; NbExp=3; IntAct=EBI-11096309, EBI-298169;
CC       Q9NYB9-2; Q9UNH6-3: SNX7; NbExp=3; IntAct=EBI-11096309, EBI-12424584;
CC       Q9NYB9-2; O60504: SORBS3; NbExp=3; IntAct=EBI-11096309, EBI-741237;
CC       Q9NYB9-2; O75886: STAM2; NbExp=3; IntAct=EBI-11096309, EBI-373258;
CC       Q9NYB9-2; Q8N4C7: STX19; NbExp=3; IntAct=EBI-11096309, EBI-8484990;
CC       Q9NYB9-2; Q12846: STX4; NbExp=3; IntAct=EBI-11096309, EBI-744942;
CC       Q9NYB9-2; Q08117-2: TLE5; NbExp=6; IntAct=EBI-11096309, EBI-11741437;
CC       Q9NYB9-2; P07951-2: TPM2; NbExp=3; IntAct=EBI-11096309, EBI-10977815;
CC       Q9NYB9-2; Q13049: TRIM32; NbExp=8; IntAct=EBI-11096309, EBI-742790;
CC       Q9NYB9-2; Q6ZMU5: TRIM72; NbExp=3; IntAct=EBI-11096309, EBI-2341648;
CC       Q9NYB9-2; Q8N7C3: TRIML2; NbExp=3; IntAct=EBI-11096309, EBI-11059915;
CC       Q9NYB9-2; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-11096309, EBI-947187;
CC       Q9NYB9-2; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-11096309, EBI-739895;
CC       Q9NYB9-2; O75604: USP2; NbExp=3; IntAct=EBI-11096309, EBI-743272;
CC       Q9NYB9-2; Q5ST30: VARS2; NbExp=3; IntAct=EBI-11096309, EBI-2116622;
CC       Q9NYB9-2; Q9UK41-2: VPS28; NbExp=3; IntAct=EBI-11096309, EBI-12146727;
CC       Q9NYB9-2; Q9UPY6-2: WASF3; NbExp=3; IntAct=EBI-11096309, EBI-12026286;
CC       Q9NYB9-2; Q9Y3C0: WASHC3; NbExp=5; IntAct=EBI-11096309, EBI-712969;
CC       Q9NYB9-2; O00401: WASL; NbExp=5; IntAct=EBI-11096309, EBI-957615;
CC       Q9NYB9-2; O43516-4: WIPF1; NbExp=3; IntAct=EBI-11096309, EBI-12052927;
CC       Q9NYB9-2; Q9NZC7-5: WWOX; NbExp=5; IntAct=EBI-11096309, EBI-12040603;
CC       Q9NYB9-2; Q8TF47: ZFP90; NbExp=3; IntAct=EBI-11096309, EBI-11419867;
CC       Q9NYB9-2; Q9H0C1: ZMYND12; NbExp=5; IntAct=EBI-11096309, EBI-12030590;
CC       Q9NYB9-2; Q6S9Z5: ZNF474; NbExp=3; IntAct=EBI-11096309, EBI-17269964;
CC       Q9NYB9-2; A0A0S2Z5X4: ZNF688; NbExp=3; IntAct=EBI-11096309, EBI-16429014;
CC       Q9NYB9-2; P0C7X2: ZNF688; NbExp=3; IntAct=EBI-11096309, EBI-4395732;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11516653,
CC       ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}. Nucleus
CC       {ECO:0000269|PubMed:7590236}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell projection, lamellipodium
CC       {ECO:0000269|PubMed:11516653, ECO:0000269|PubMed:15572692}. Cell
CC       projection, filopodium {ECO:0000269|PubMed:11516653}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:15572692}. Cell junction, adherens
CC       junction {ECO:0000269|PubMed:15572692}. Note=Isoform 1 but not isoform
CC       3 is localized to protruding lamellipodia and filopodia tips
CC       (PubMed:11516653, PubMed:15572692). Present at nascent adherens
CC       junctions, where it clusters adjacent to the tips of F-actin
CC       protrusions (PubMed:15572692). {ECO:0000269|PubMed:11516653,
CC       ECO:0000269|PubMed:15572692}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Abi-2b;
CC         IsoId=Q9NYB9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYB9-2; Sequence=VSP_010761, VSP_010762, VSP_010763;
CC       Name=3; Synonyms=Abi-2a;
CC         IsoId=Q9NYB9-3; Sequence=VSP_010759, VSP_010760, VSP_010761,
CC                                  VSP_010762;
CC       Name=4;
CC         IsoId=Q9NYB9-4; Sequence=VSP_010761;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Abundant in testes, ovary,
CC       thymus, and colon, with lower but detectable levels in prostate,
CC       peripheral blood leukocytes, and spleen. {ECO:0000269|PubMed:7590236}.
CC   -!- DOMAIN: The SH3 domain is critical for binding to ABL1 and ABL2.
CC       {ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}.
CC   -!- PTM: Phosphorylated by ABL1. {ECO:0000269|PubMed:7590236}.
CC   -!- DISEASE: Note=There is evidence, including phenotypic data from ABI2-
CC       knockout mice, that loss-of-function variants in ABI2 may play a role
CC       in autosomal recessive intellectual disability.
CC       {ECO:0000269|PubMed:28397838}.
CC   -!- SIMILARITY: Belongs to the ABI family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U23435; AAA92289.1; -; mRNA.
DR   EMBL; U31089; AAA75446.1; -; mRNA.
DR   EMBL; AF260261; AAF70308.1; -; mRNA.
DR   EMBL; X95632; CAA64885.1; -; mRNA.
DR   EMBL; BT009920; AAP88922.1; -; mRNA.
DR   EMBL; AK299824; BAG61693.1; -; mRNA.
DR   EMBL; BC001439; AAH01439.1; -; mRNA.
DR   CCDS; CCDS2358.1; -. [Q9NYB9-2]
DR   CCDS; CCDS63093.1; -. [Q9NYB9-1]
DR   CCDS; CCDS63094.1; -. [Q9NYB9-4]
DR   PIR; G01936; G01936.
DR   RefSeq; NP_001269854.1; NM_001282925.1.
DR   RefSeq; NP_001269855.1; NM_001282926.1.
DR   RefSeq; NP_001269856.1; NM_001282927.2. [Q9NYB9-3]
DR   RefSeq; NP_001362683.1; NM_001375754.1. [Q9NYB9-3]
DR   RefSeq; NP_005750.4; NM_005759.5. [Q9NYB9-2]
DR   RefSeq; XP_006712248.1; XM_006712185.1.
DR   PDB; 2ED0; NMR; -; A=444-508.
DR   PDB; 3P8C; X-ray; 2.29 A; F=1-154.
DR   PDB; 4N78; X-ray; 2.43 A; F=1-513.
DR   PDB; 7USC; EM; 3.00 A; E=1-154.
DR   PDB; 7USD; EM; 3.00 A; E=1-154.
DR   PDB; 7USE; EM; 3.00 A; E=1-154.
DR   PDBsum; 2ED0; -.
DR   PDBsum; 3P8C; -.
DR   PDBsum; 4N78; -.
DR   PDBsum; 7USC; -.
DR   PDBsum; 7USD; -.
DR   PDBsum; 7USE; -.
DR   AlphaFoldDB; Q9NYB9; -.
DR   BMRB; Q9NYB9; -.
DR   SMR; Q9NYB9; -.
DR   BioGRID; 115454; 298.
DR   DIP; DIP-37566N; -.
DR   FunCoup; Q9NYB9; 1508.
DR   IntAct; Q9NYB9; 262.
DR   MINT; Q9NYB9; -.
DR   STRING; 9606.ENSP00000295851; -.
DR   MoonDB; Q9NYB9; Predicted.
DR   GlyGen; Q9NYB9; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q9NYB9; -.
DR   PhosphoSitePlus; Q9NYB9; -.
DR   BioMuta; ABI2; -.
DR   DMDM; 50400673; -.
DR   CPTAC; CPTAC-1593; -.
DR   jPOST; Q9NYB9; -.
DR   MassIVE; Q9NYB9; -.
DR   PaxDb; 9606-ENSP00000295851; -.
DR   PeptideAtlas; Q9NYB9; -.
DR   ProteomicsDB; 83209; -. [Q9NYB9-1]
DR   ProteomicsDB; 83210; -. [Q9NYB9-2]
DR   ProteomicsDB; 83211; -. [Q9NYB9-3]
DR   ProteomicsDB; 83212; -. [Q9NYB9-4]
DR   Pumba; Q9NYB9; -.
DR   Antibodypedia; 34165; 224 antibodies from 31 providers.
DR   DNASU; 10152; -.
DR   Ensembl; ENST00000261017.9; ENSP00000261017.5; ENSG00000138443.17. [Q9NYB9-2]
DR   GeneID; 10152; -.
DR   KEGG; hsa:10152; -.
DR   UCSC; uc002uzz.5; human. [Q9NYB9-1]
DR   AGR; HGNC:24011; -.
DR   CTD; 10152; -.
DR   DisGeNET; 10152; -.
DR   GeneCards; ABI2; -.
DR   HGNC; HGNC:24011; ABI2.
DR   HPA; ENSG00000138443; Low tissue specificity.
DR   MIM; 606442; gene.
DR   OpenTargets; ENSG00000138443; -.
DR   VEuPathDB; HostDB:ENSG00000138443; -.
DR   eggNOG; KOG2546; Eukaryota.
DR   GeneTree; ENSGT00940000156089; -.
DR   InParanoid; Q9NYB9; -.
DR   OrthoDB; 2159336at2759; -.
DR   PAN-GO; Q9NYB9; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NYB9; -.
DR   PathwayCommons; Q9NYB9; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013404; RAC2 GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   Reactome; R-HSA-9664422; FCGR3A-mediated phagocytosis.
DR   SignaLink; Q9NYB9; -.
DR   SIGNOR; Q9NYB9; -.
DR   BioGRID-ORCS; 10152; 10 hits in 1158 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; ABI2; human.
DR   EvolutionaryTrace; Q9NYB9; -.
DR   GeneWiki; ABI2; -.
DR   GenomeRNAi; 10152; -.
DR   Pharos; Q9NYB9; Tbio.
DR   PRO; PR:Q9NYB9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9NYB9; protein.
DR   Bgee; ENSG00000138443; Expressed in Brodmann (1909) area 23 and 194 other cell types or tissues.
DR   ExpressionAtlas; Q9NYB9; baseline and differential.
DR   GO; GO:0098858; C:actin-based cell projection; IBA:GO_Central.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0032433; C:filopodium tip; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0031209; C:SCAR complex; IDA:UniProtKB.
DR   GO; GO:0008093; F:cytoskeletal anchor activity; TAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019900; F:kinase binding; NAS:UniProtKB.
DR   GO; GO:0070064; F:proline-rich region binding; IPI:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IPI:UniProtKB.
DR   GO; GO:0035591; F:signaling adaptor activity; IDA:ARUK-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; NAS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; TAS:UniProtKB.
DR   GO; GO:0048858; P:cell projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0007010; P:cytoskeleton organization; TAS:UniProtKB.
DR   GO; GO:0070309; P:lens fiber cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0000423; P:mitophagy; IDA:UniProt.
DR   GO; GO:0001764; P:neuron migration; IBA:GO_Central.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI.
DR   GO; GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IDA:UniProtKB.
DR   GO; GO:0010592; P:positive regulation of lamellipodium assembly; IDA:ARUK-UCL.
DR   GO; GO:0016601; P:Rac protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0045186; P:zonula adherens assembly; IMP:UniProtKB.
DR   CDD; cd11972; SH3_Abi2; 1.
DR   DisProt; DP02386; -.
DR   FunFam; 2.30.30.40:FF:000002; abl interactor 1 isoform X1; 1.
DR   Gene3D; 6.10.140.1620; -; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR035726; Abi2_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460:SF26; ABL INTERACTOR 2; 1.
DR   PANTHER; PTHR10460; ABL INTERACTOR FAMILY MEMBER; 1.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR01217; PRICHEXTENSN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
DR   neXtProt; NX_Q9NYB9; -.
DR   PharmGKB; PA134977642; -.
DR   TreeFam; TF314303; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell projection;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Disease variant;
KW   Host-virus interaction; Intellectual disability; Neurogenesis; Nucleus;
KW   Phosphoprotein; Proteomics identification; Reference proteome; SH3 domain.
FT   CHAIN           1..513
FT                   /note="Abl interactor 2"
FT                   /id="PRO_0000191790"
FT   DOMAIN          45..107
FT                   /note="t-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00202"
FT   DOMAIN          451..510
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          167..431
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        174..185
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        217..241
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        242..272
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        273..282
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        283..325
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        376..399
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        400..409
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P62484"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         361
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P62484"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..45
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7590236"
FT                   /id="VSP_010759"
FT   VAR_SEQ         46..95
FT                   /note="ALEETKAYTTQSLASVAYLINTLANNVLQMLDIQASQLRRMESSINHISQ
FT                   -> MSCRCWISRHPSYEGWNLQSIIFHKQIRGVDLESTFVTKFGNNCSLRLNE (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7590236"
FT                   /id="VSP_010760"
FT   VAR_SEQ         154..159
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7590236,
FT                   ECO:0000303|PubMed:8649853, ECO:0000303|Ref.2,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_010761"
FT   VAR_SEQ         284..344
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7590236, ECO:0000303|PubMed:8649853,
FT                   ECO:0000303|Ref.2, ECO:0000303|Ref.4"
FT                   /id="VSP_010762"
FT   VAR_SEQ         399
FT                   /note="S -> SLAPPPPSILQVTPQLPLMGFVARVQENIS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:8649853, ECO:0000303|Ref.2,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_010763"
FT   VARIANT         132..513
FT                   /note="Missing (found in a consanguineous family with
FT                   autosomal recessive intellectual disability; likely
FT                   pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:28397838"
FT                   /id="VAR_080776"
FT   CONFLICT        22
FT                   /note="S -> R (in Ref. 3; CAA64885)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="A -> D (in Ref. 3; CAA64885)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        243
FT                   /note="S -> T (in Ref. 2; AAA75446)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249
FT                   /note="G -> P (in Ref. 1; AAA92289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        317
FT                   /note="N -> D (in Ref. 5; BAG61693)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324..325
FT                   /note="PN -> QT (in Ref. 5; BAG61693)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        432
FT                   /note="A -> V (in Ref. 2; AAA75446)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        500
FT                   /note="F -> S (in Ref. 2; AAA75446)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1..9
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           11..39
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           43..110
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            143..151
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          453..458
FT                   /evidence="ECO:0007829|PDB:2ED0"
FT   STRAND          477..483
FT                   /evidence="ECO:0007829|PDB:2ED0"
FT   STRAND          485..493
FT                   /evidence="ECO:0007829|PDB:2ED0"
FT   STRAND          496..501
FT                   /evidence="ECO:0007829|PDB:2ED0"
FT   STRAND          504..507
FT                   /evidence="ECO:0007829|PDB:2ED0"
SQ   SEQUENCE   513 AA;  55663 MW;  822983A69E5EA512 CRC64;
     MAELQMLLEE EIPGGRRALF DSYTNLERVA DYCENNYIQS ADKQRALEET KAYTTQSLAS
     VAYLINTLAN NVLQMLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANL ERPVRYIRKP IDYTILDDIG HGVKWLLRFK VSTQNMKMGG LPRTTPPTQK
     PPSPPMSGKG TLGRHSPYRT LEPVRPPVVP NDYVPSPTRN MAPSQQSPVR TASVNQRNRT
     YSSSGSSGGS HPSSRSSSRE NSGSGSVGVP IAVPTPSPPS VFPAPAGSAG TPPLPATSAS
     APAPLVPATV PSSTAPNAAA GGAPNLADGF TSPTPPVVSS TPPTGHPVQF YSMNRPASRH
     TPPTIGGSLP YRRPPSITSQ TSLQNQMNGG PFYSQNPVSD TPPPPPPVEE PVFDESPPPP
     PPPEDYEEEE AAVVEYSDPY AEEDPPWAPR SYLEKVVAIY DYTKDKEDEL SFQEGAIIYV
     IKKNDDGWYE GVMNGVTGLF PGNYVESIMH YSE
//
